Literature DB >> 16850677

Spectrum of bone tumors in Chiang Mai University Hospital, Thailand according to WHO classification 2002: A study of 1,001 cases.

Jongkolnee Settakorn1, Suree Lekawanvijit, Olarn Arpornchayanon, Samreung Rangdaeng, Pramote Vanitanakom, Sarawut Kongkarnka, Ruangrong Cheepsattayakorn, Charin Ya-In, Paul S Thorner.   

Abstract

OBJECTIVE: The aim of the present study was to determine the spectrum, frequency and demographics of bone tumors. MATERIAL AND
METHOD: A retrospective study of the 1,001 bone tumor specimens from the files at the Pathology Department of the Chiang Mai University Hospital, Thailand from 2000 to 2004.
RESULTS: From the study, 41 were non-neoplastic mass lesions, and 960 were neoplastic, with 856 (89%) as primary and 104 (11%) as metastatic tumors. In the primary tumor group, 654 (76%) cases were of hematologic origin, and 202 (24%) were non-hematologic. The most common benign bone tumors were giant cell tumor (n = 37), osteochondroma (n = 25), and chondroma (n = 15). The most common malignant bone tumors were lymphoma-leukemia (n = 583), metastatic malignancy (n = 104), plasma cell myeloma (n = 71), and osteosarcoma (n = 58).
CONCLUSION: The present study showed a higher frequency of osteosarcoma (68%), lower frequencies of chondrosarcoma (12%) and Ewing sarcoma (4%) among primary non-hematologic malignant bone tumors when compared with similar studies based on Western patients. Whether these differences reflect differences in the ethnic population or in practice patterns remains to be determined

Entities:  

Mesh:

Year:  2006        PMID: 16850677

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  10 in total

1.  Use of warm Ringer's lactate solution in the management of locally advanced giant cell tumor of bone.

Authors:  Saranatra Waikakul; Apichat Asavamongkolkul; Rapin Phimolsarnti
Journal:  Int J Clin Oncol       Date:  2015-06-28       Impact factor: 3.402

2.  Total Knee Arthroplasty and Atypical Cartilaginous Tumor/Enchondroma of the Distal Femur.

Authors:  Seyed Mohammad Javad Mortazavi; Mohammadreza Razzaghof; Alireza Moharrami; Ahmad Shamabadi; Abbas Noori
Journal:  Arthroplast Today       Date:  2020-07-22

3.  Treatment of giant cell tumor of bone: Current concepts.

Authors:  Ajay Puri; Manish Agarwal
Journal:  Indian J Orthop       Date:  2007-04       Impact factor: 1.251

4.  Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1).

Authors:  Barry P Pereira; Yefang Zhou; Anurag Gupta; David T Leong; Khin Zarchi Aung; Ling Ling; Robert W H Pho; Mario Galindo; Manuel Salto-Tellez; Gary S Stein; Simon M Cool; Andre J van Wijnen; Saminathan S Nathan
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

5.  Role of Bisphosphonates as Adjuvants of Surgery in Giant Cell Tumor of Spine.

Authors:  Chaitanya Dev Pannu; Pankaj Kandhwal; Vijay Raghavan; Shah Alam Khan; Shishir Rastogi; Arvind Jayaswal
Journal:  Int J Spine Surg       Date:  2018-12-21

6.  Osteochondroma: Review of 431 patients from one medical institution in South China.

Authors:  Kai Tong; Hongzhe Liu; Xiang Wang; Ziyi Zhong; Shenglu Cao; Chengjie Zhong; YunPing Yang; Gang Wang
Journal:  J Bone Oncol       Date:  2017-08-30       Impact factor: 4.072

7.  Exploring targeted therapy of osteosarcoma using proteomics data.

Authors:  Parunya Chaiyawat; Jongkolnee Settakorn; Apiruk Sangsin; Pimpisa Teeyakasem; Jeerawan Klangjorhor; Aungsumalee Soongkhaw; Dumnoensun Pruksakorn
Journal:  Onco Targets Ther       Date:  2017-02-01       Impact factor: 4.147

8.  Epidemiology of musculoskeletal tumors in Shiraz, south of Iran.

Authors:  Saeed Solooki; Amir Reza Vosoughi; Vahid Masoomi
Journal:  Indian J Med Paediatr Oncol       Date:  2011-10

9.  Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.

Authors:  Parunya Chaiyawat; Jeerawan Klangjorhor; Jongkolnee Settakorn; Voraratt Champattanachai; Areerak Phanphaisarn; Pimpisa Teeyakasem; Jisnuson Svasti; Dumnoensun Pruksakorn
Journal:  Transl Oncol       Date:  2017-09-04       Impact factor: 4.243

10.  Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications.

Authors:  Parunya Chaiyawat; Dumnoensun Pruksakorn; Areerak Phanphaisarn; Pimpisa Teeyakasem; Jeerawan Klangjorhor; Jongkolnee Settakorn
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.